• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Document › Details

bioMérieux S.A.. (4/24/19). "Press Release: bioMérieux – First-Quarter 2019 Business Review". Marcy l’Étoile.

	Organisation	bioMérieux S.A. (Euronext: BIM)
	Group	Mérieux (Group)
	Organisation 2	Invisible Sentinel Inc.
	Group	Mérieux (Group)
	Product	molecular diagnostics
	Product 2	in vitro diagnostics (IVD)
	Person	Mérieux, Alexandre (Mérieux 201712– CEO at bioMérieux before Deputy CEO before VP Industrial Microbiology)

> Organic growth of 3.8% (at constant exchange rates and scope of consolidation)

>> €632 million in sales
>> Up 7.7% as reported

> Growth led by the performance in molecular biology, during a first quarter shaped by a flu season of moderate intensity, and by strong sales momentum in the Asia Pacific region


Alexandre Mérieux, Chairman and Chief Executive Officer, said: “Consolidated sales continued to grow in the first quarter of 2019. However, the growth rate was moderate, as expected, due primarily to a less intense flu season and a slower start to the year in Europe and in equipment sales. Today, we are confirming the annual objectives set for 2019.”


bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2019.


SALES

Consolidated sales amounted to €632 million in the first quarter of 2019, up from €587 million in the year-earlier period. As expected, sales growth at constant exchange rates and scope of consolidation was below the annual objective, at 3.8%, due to an unfavorable basis of comparison related to the flu season. Reported growth in euros came to 7.7%, reflecting a positive currency effect of €17 million driven by the rise in the US dollar, as well as the impact of changes in the scope of consolidation, which mainly correspond to the sales generated by Hybiome and Invisible Sentinel.


Download [ Full Release https://www.biomerieux.com/sites/corporate/files/news-event-press-release/biomerieux_pr_sales_q1_2019.pdf ]

Record changed: 2019-04-30

Advertisement

More documents for Mérieux (Group)

• [1] bioMérieux S.A.. (6/6/19). "Press Release: bioMérieux Increases Its Holding in Hybiome from 54% to 67%". Marcy l’Étoile....
• [2] bioMérieux S.A.. (4/15/19). "Press Release: “Global-PPS”, a Survey of Antibiotic Use and Bacterial Resistance in Hospitals Worldwide, Tops the 200,000 Patients". Marcy l’Étoile & Antwerp....
• [3] bioMérieux S.A.. (4/1/19). "Press Release: University of Antwerp, bioMérieux, and Wellcome Trust to Coordinate VALUE-Dx, a European Public-Private Partnership to Fight Antimicrobial Resistance through Diagnostics". Antwerp, London & Marcy l’Eoile....
• [4] bioMérieux S.A.. (3/19/19). "Press Release: Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury". Deerfield, IL & Marcy l’Etoile....
• [5] bioMérieux S.A.. (2/27/19). "Press Release: bioMérieux – 2018 Financial Results"....
• [6] bioMérieux S.A.. (2/7/19). "Press Release: bioMérieux Acquires Invisible Sentinel, a US-based Company Specialized in Food and Beverage Molecular Testing". Marcy l’Étoile....
• [7] bioMérieux S.A.. (11/13/18). "Press Release: bioMérieux Launches the BioFire FilmArray Pneumonia Panels with FDA Clearance and CE Marking". Marcy l’Étoile....
• [8] bioMérieux S.A.. (11/9/18). "Press Release: bioMérieux Acquires a Majority Stake in Hybiome and Strengthens Its Presence Both in China and in the Immunoassay Market". Marcy l’Étoile....
• [9] bioMérieux S.A.. (7/18/18). "Press Release: Second-Quarter 2018 Business Review"....
• [10] bioMérieux S.A.. (5/31/18). "Press Release: bioMérieux Launches Endozyme II GO, an Innovative Test for the Detection of Endotoxins in Pharmaceutical Microbiology Control". Marcy l’Étoile....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2020. Made in Germany.